Search Results

With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector

Mercury Bio today announced that it has joined the Alliance for mRNA Medicines as a charter member, and that Chief Science Officer Richard Sayre, Ph.D. has joined the Alliance for mRNA Medicines (AMM) board.

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM-based biotech company commercializing an innovative and highly disruptive drug delivery platform

Mercury Bio, (www.mercurybio.com) a Santa Fe, NM–based biotech company commercializing an innovative and highly disruptive drug delivery platform, today announced that Chief Executive Officer Bruce McCormick and Chief Science Officer Richard Sayre, Ph.D., will be presenting at the 2024 Biotech Showcase investors and corporate development conference at 11:00 AM on Monday, January 8, 2024.

Mercury Bio has entered into a joint research, development, and licensing agreement with Old Bethpage, NY -based Himed.

Mercury Bio, a Santa Fe, NM-based biotech company working in the area of targeted molecular drug delivery, achieved two financial milestones in the first half of August as it concluded a $2M seed funding round, and welcomed John Tomes as Finance Director for the growing company.

Mercury Medical recently received MDR CE Mark Certification for their CPR manual resuscitation line.

Medovate has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA.

POM Medical, LLC has expanded their Mercury Medical US Distribution Partnership with the signing of a European Distribution Agreement

Senzime has selected Mercury Medical as their exclusive United States provider of Biomedical repair and maintenance services for their TetraGraph product line.